Patents by Inventor Sherrie Pietranico

Sherrie Pietranico has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120230951
    Abstract: The present invention provides compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    Type: Application
    Filed: March 8, 2012
    Publication date: September 13, 2012
    Inventors: Muzaffar Alam, Steven Joseph Berthel, John A. Brinkman, Ronald Charles Hawley, Hongju Li, Wylie Solang Palmer, Sherrie Pietranico-Cole, Ramakanth Sarabu, Mark Smith, Sung-Sau So, Lin Yi, Yansheng Zhai, Qiang Zhang, Shu-Hai Zhao
  • Publication number: 20070155671
    Abstract: A compound of formula 1a which is useful for treating reperfusion injury, and salts, prodrugs, and related compounds.
    Type: Application
    Filed: February 8, 2007
    Publication date: July 5, 2007
    Inventors: Nader Fotouhi, Paul Gillespie, Robert Guthrie, Sherrie Pietranico-Cole, Weiya Yun
  • Publication number: 20070049632
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.
    Type: Application
    Filed: August 18, 2006
    Publication date: March 1, 2007
    Inventors: Bruce Banner, Joseph Bilotta, Nader Fotouhi, Paul Gillespie, Robert Goodnow, Matthew Hamilton, Nancy-Ellen Haynes, Agnieszka Kowalczyk, Alexander Mayweg, Michael Myers, Sherrie Pietranico-Cole, Nathan Scott, Kshitij Thakkar, Jefferson Tilley
  • Publication number: 20070032494
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as obesity, hyperlipidemia, hypercholesterolemia and diabetes and other related disorders and diseases, and may be useful for other diseases such as NASH, atherosclerosis, cardiovascular diseases, hypothyroidism, thyroid cancer and other disorders and diseases related thereto.
    Type: Application
    Filed: July 18, 2006
    Publication date: February 8, 2007
    Inventors: Nancy-Ellen Haynes, Denis Kertesz, Sherrie Pietranico-Cole, Yimin Qian, Nathan Scott, Sung-Sau So, Kshitij Thakkar, Jefferson Tilley
  • Publication number: 20050080119
    Abstract: A compound of formula 1a which is useful for treating reperfusion injury, and salts, prodrugs, and related compounds.
    Type: Application
    Filed: September 21, 2004
    Publication date: April 14, 2005
    Inventors: Nader Fotouhi, Paul Gillespie, Robert Guthrie, Sherrie Pietranico-Cole, Weiya Yun
  • Patent number: 6197963
    Abstract: Compounds are provided which are crossreactive with peptides such as those which bind G-protein-linked receptors, together with preparative and therapeutic methods therefor. The compounds have the general structure: wherein at least one of R1, R2, R3, R4, or R5 comprises a functional group which is chemically similar to that found in the peptide of interest.
    Type: Grant
    Filed: August 13, 1998
    Date of Patent: March 6, 2001
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Ralph Hirschmann, John Hynes, Jr., Maria A. Cichy-Knight, Rachel D. van Rijn, Paul A. Sprengeler, P. Grant Spoors, William C. Shakespeare, Sherrie Pietranico-Cole, Amos B. Smith, III
  • Patent number: 5552534
    Abstract: Compounds are provided which are crossreactive with peptides such as those which bind G-protein-linked receptors, together with preparative and therapeutic methods therefor. The compounds have the general structure: ##STR1## wherein at least one of R.sub.1, R.sub.2, R.sub.3, R.sub.4, or R.sub.5 comprises a functional group which is chemically similar to that found in the peptide of interest.
    Type: Grant
    Filed: October 28, 1993
    Date of Patent: September 3, 1996
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Ralph F. Hirschmann, Kyriacos C. Nicolaou, Sherrie Pietranico, T. R. Reisine, Joseph M. Salvino, Paul Sprengeler, Catherine D. Strader